Moreover, blocking autophagy using pharmacological blockers (CQN), or silencing of ATG5 and ATG7, significantly enhanced the killing of imatinib-resistant cells in chronic myelogenous leukemia [43]. This evidence concerns the gene ATG5 and chronic myelogenous leukemia, BCR-ABL1 positive.